EU Biotech Act: A New Opportunity to Strengthen European Life Sciences Supply Chains?
Europe is entering a new phase in its biotechnology strategy. The proposed EU Biotech Act could become an important catalyst for strengthening European competitiveness, accelerating innovation and developing more resilient life sciences supply chains. But what does this mean in practice for the industry? The European Commission’s proposal for the EU Biotech Act, presented in…
